Synaptogenix Inc. (SNPX)
NASDAQ: SNPX
· Real-Time Price · USD
7.85
1.80 (29.86%)
At close: Jun 30, 2025, 3:59 PM
Synaptogenix Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | 10.27K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | 1.18K | n/a | 1.32K | 1.4K | 1.21K | 1.72K | 1.72K | n/a | 1.53K | 1.49K | 1.38K | 1.32K | 1.24K | 1.24K | 1.24K | 1.25K |
Gross Profit | n/a | n/a | n/a | -1.32K | -1.4K | 9.06K | -1.72K | -1.72K | n/a | -1.53K | -1.49K | -1.38K | -1.32K | -1.24K | -1.24K | -1.24K | -1.25K |
Operating Income | n/a | -2.18M | -1.36M | -1.58M | -1.69M | -2.13M | -763.2K | 4.09M | -2.92M | -5.89M | -3.17M | -3.8M | -3.28M | -4.23M | -2.92M | -2.29M | -3.16M |
Interest Income | 182.33K | 181.3K | 300.68K | 330.51K | 463.39K | 275.44K | 550K | 427.16K | 396.36K | 145.21K | 140.73K | 44.49K | 4.61K | 2.52K | 2.44K | 1.33K | 816.00 |
Pretax Income | 385.17K | -5.55M | -5.74M | -1.27M | -206.7K | -995.97K | 763.2K | -4.09M | -1.71M | 4.48M | -3.03M | -3.75M | -3.28M | -4.24M | -2.93M | -2.29M | -3.15M |
Net Income | 167.84K | -5.55M | -5.74M | -1.27M | -206.7K | -995.97K | 763.2K | -4.09M | -1.71M | 4.48M | -3.17M | -3.8M | -3.28M | -4.24M | -2.93M | -2.29M | -3.15M |
Selling & General & Admin | 1.01M | 1.75M | 1.14M | 1.24M | 1.08M | 1.55M | 1.22M | 1.52M | 2.04M | 4.48M | 1.68M | 1.86M | 1.8M | 2.88M | 2.09M | 1.31M | 2M |
Research & Development | 60.82K | 424.51K | 222.9K | 342.07K | 609.25K | 577.89K | 212.1K | 307.21K | 877.72K | 1.41M | 1.48M | 1.94M | 1.49M | 1.36M | 836.72K | 986.28K | 1.15M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 1.07M | 2.18M | 1.36M | 1.58M | 1.69M | 2.13M | 1.43M | 1.83M | 2.92M | 5.89M | 3.17M | 3.8M | 3.28M | 4.24M | 2.93M | 2.3M | 3.16M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | -1.4K | -1.21K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | n/a | 2.18M | 1.36M | 1.58M | 1.69M | 2.13M | 1.43M | 1.83M | 2.92M | 5.89M | 3.17M | 3.8M | 3.28M | 4.24M | 2.93M | 2.3M | 3.16M |
Income Tax Expense | 217.33K | -789.91B | n/a | n/a | n/a | n/a | -1.12M | -6.12M | n/a | n/a | 140.73K | 44.49K | 4.61K | 2.52K | 2.44K | 1.33K | -1.63K |
Shares Outstanding (Basic) | 1.39M | 1.23M | 1.25M | 1.07M | 1.04M | 686K | 428.2K | 118K | 259K | 290K | 279K | 277K | 277K | 271K | 247K | 158K | 118K |
Shares Outstanding (Diluted) | 1.39M | 1.23M | 1.32M | 1.21M | 1.04M | 847.16K | 428.2K | 294.5K | 300.1K | 282.78K | 279.52K | 278.38K | 277.57K | 271.99K | 247.86K | 158.85K | 118.76K |
EPS (Basic) | 0.12 | -4.58 | -4.58 | -1.18 | -0.41 | -1.45 | -0.84 | -34.67 | -6.59 | 15.44 | -10.83 | -13.48 | -11.81 | -15.57 | -11.81 | -14.44 | -26.56 |
EPS (Diluted) | 0.04 | -4.58 | -4.58 | -1.18 | -0.41 | -1.45 | -0.84 | -34.67 | -6.59 | 15.44 | -10.83 | -13.5 | -11.81 | -15.57 | -11.81 | -14.44 | -26.56 |
EBITDA | n/a | -2.18M | -1.36M | -1.58M | -1.69M | -2.13M | -1.43M | -1.83M | -2.92M | -5.89M | -3.17M | -3.8M | -3.28M | -4.24M | -2.93M | -2.29M | -3.15M |
EBIT | n/a | -2.18M | -1.36M | -1.58M | -1.69M | -2.13M | -1.43M | -1.83M | -2.92M | -5.89M | -3.17M | -3.8M | -3.28M | -4.24M | -2.93M | -2.3M | -3.16M |
Depreciation & Amortization | n/a | 1.18K | 1.69K | 1.32K | 1.4K | 1.21K | 1.72K | 1.72K | 1.69K | 1.53K | 1.49K | 1.38K | 1.32K | 1.24K | 1.24K | 1.24K | 1.25K |